A practical reference on GLP-1 analogue: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2025-11-26. Anything still debated is marked as such rather than presented as settled.
The sequence incorporates alpha-aminoisobutyric acid at position 8, replacing the alanine found in the natural hormone. This substitution blocks the primary DPP-4 recognition site and contributes most of the enzymatic stability. Albumin binding further protects the peptide and reduces the frequency of administration required to maintain active plasma levels. Because the fatty acid chain increases lipophilicity, the compound is formulated as a solution rather than a simple aqueous buffer. Researchers describe the design as an incremental optimization of earlier GLP-1 analogs rather than a wholly new scaffold.
Reported molecular weight is approximately 4113.6 daltons for the free base, and the peptide is supplied as a lyophilized powder or in buffered liquid form depending on the intended use. It is freely soluble in water when formulated with appropriate excipients, though the unconjugated peptide shows limited stability at neutral pH over long periods. Analytical characterization typically relies on reversed-phase high-performance liquid chromatography and mass spectrometry. Purity specifications for research-grade material commonly exceed ninety-five percent by area. Isotopic and impurity profiles differ between suppliers.
The semaglutide sequence is a 31-residue analogue of human GLP-1, altered at three positions relative to the parent hormone. Aminoisobutyric acid replaces alanine at position 8, arginine replaces lysine at position 34, and a lipophilic diacid is attached to lysine 26 through a short linker. These features are reported consistently in the structural literature. The position 8 substitution blocks recognition by dipeptidyl peptidase-4, while the attached chain drives strong, reversible association with a carrier protein in blood.
Receptor activation raises intracellular cyclic AMP through Gs coupling, which promotes glucose-dependent insulin release and suppresses glucagon secretion when blood glucose is elevated. Effects outside the pancreas include slower gastric emptying and altered appetite signalling in the hypothalamus and hindbrain. The relative contribution of each tissue to overall metabolic outcomes remains an area of active investigation. Central mechanisms in particular are inferred mainly from animal models and indirect human measures rather than direct observation.
Serum protein binding dominates the pharmacokinetic profile. The attached chain associates strongly with albumin, shielding the peptide from enzymatic attack and slowing filtration by the kidney. This interaction extends the circulation half-life to roughly one week in humans, which supports weekly administration intervals. An oral version pairs the peptide with an absorption enhancer that transiently alters gastric epithelium, permitting limited uptake; bioavailability by that route is substantially lower than by injection.
| Property | Value | Notes |
|---|---|---|
| Molecular formula (free base) | C187H291N45O59 | Approximate; salt and hydrate forms differ |
| Molecular weight | ~4113.6 Da | Varies with counterion and hydration |
| Appearance | White to off-white powder | Lyophilized research material |
| Solubility class | Freely soluble in water | As formulated; native peptide less stable near neutral pH |
| Typical storage | 2 to 8 degrees Celsius | Protect from light; avoid repeated freeze-thaw |
Storage at minus 20 degrees Celsius or lower in a desiccated container preserves the peptide for extended periods, while working solutions are commonly held at two to eight degrees Celsius for short intervals. Light exposure and repeated freeze-thaw cycles accelerate degradation, so dividing material into single-use aliquots is generally recommended. Adsorption to glass and plastic surfaces can lower the measured concentration of dilute solutions, particularly below one milligram per millilitre. The degradation routes most often reported for GLP-1 analogues are deamidation, methionine oxidation, and backbone hydrolysis. Relative rates under specific conditions are frequently described only for individual formulations.
Reverse-phase high-performance liquid chromatography with ultraviolet detection near 214 or 280 nanometres is widely used to assess purity and to resolve related impurities. Liquid chromatography coupled to mass spectrometry confirms identity through the protonated molecular ion and fragment ions formed in tandem experiments. Capillary electrophoresis and peptide mapping after enzymatic digestion supply complementary information on charge variants and modification sites. Circular dichroism and nuclear magnetic resonance can report on secondary structure in solution. Absolute quantification usually depends on an external standard, and reported purity depends on the detection wavelength and integration parameters chosen.
Two structural features account for the prolonged half-life of semaglutide. A modified amino acid at position 8 resists cleavage by dipeptidyl peptidase-4, the enzyme that rapidly degrades native GLP-1. A fatty diacid side chain binds serum albumin, which limits renal clearance and protects the peptide from enzymatic breakdown. These modifications yield a plasma half-life of approximately one week in humans, allowing once-weekly administration. The relationship between plasma concentration and clinical effect varies between individuals, and sources of that variability are still being characterized.
Semaglutide is a synthetic peptide analog of glucagon-like peptide-1 (GLP-1), a hormone released from intestinal L-cells after food intake. The compound belongs to the incretin mimetic class and acts at GLP-1 receptors distributed across pancreatic, gastrointestinal, cardiovascular, and central nervous system tissues. Compared with native GLP-1, the molecule carries structural changes that extend its activity from minutes to roughly one week. It is studied for glycemic control in type 2 diabetes and for weight management, and its effects on cardiovascular and other outcomes remain active research areas.
Receptor binding triggers G protein signaling that raises intracellular cyclic AMP in pancreatic beta cells. Insulin release follows in a glucose-dependent manner, so secretion increases when blood glucose is elevated and diminishes when it is not. The same signaling suppresses glucagon release from alpha cells and slows gastric emptying, which blunts the post-meal glucose rise. In the brain, receptor activation in regions such as the arcuate nucleus is associated with reduced appetite and lower energy intake. How much each of these effects contributes to overall weight change is not fully settled.
Identity and purity are usually assessed by reverse-phase high-performance liquid chromatography coupled to mass spectrometry. Retention time and observed mass are compared against a reference standard run under identical conditions. Impurity profiles reveal deamidation products, oxidized methionine variants, and truncated fragments that arise during synthesis or storage. Peptide mapping through enzymatic digestion confirms the primary sequence, while amino acid analysis offers an independent check on overall composition.
Stability studies examine how temperature, pH, and moisture influence degradation rates over time. In aqueous solution, hydrolysis and deamidation accelerate as pH moves away from mildly acidic conditions. Light exposure and residual metal ions can also trigger oxidation of susceptible residues. Accelerated aging at elevated temperature is used to estimate shelf life, though extrapolation to room temperature carries uncertainty because individual degradation pathways do not always scale predictably.
Receptor activation follows the canonical Gs pathway: binding increases intracellular cyclic AMP, which promotes protein kinase A activity. In pancreatic beta cells this amplifies glucose-dependent insulin release, so secretion rises when blood glucose is high and changes little when it is low. The same signalling suppresses glucagon release from alpha cells and slows gastric emptying. Receptors in the hypothalamus and brainstem are thought to contribute to reduced appetite and lower energy intake. Which of these effects dominates clinical outcomes remains an area of active study.
Semaglutide is a synthetic peptide analogue of glucagon-like peptide-1, a gut hormone released by intestinal L cells after food intake. The natural hormone acts on pancreatic and central receptors but is degraded within minutes by dipeptidyl peptidase-4 and other peptidases. Semaglutide belongs to the class of long-acting GLP-1 receptor agonists, a group distinguished by structural changes that slow breakdown and extend circulation time. Its development followed earlier short-acting analogues and reflects a general strategy in peptide drug design: preserve receptor activity while blocking proteolytic clearance.
Ubiquitin is a small (8.6 kDa) regulatory protein found in most tissues of eukaryotic organisms, i.e., it is found ubiquitously. It was discovered in 1975 by Gideon Goldstein and further characterized throughout the late 1970s and 1980s. Four genes in the human genome code for ubiquitin: UBB, UBC, UBA52 and RPS27A. The addition of ubiquitin to a substrate protein is called ubiquitylation (or ubiquitination or ubiquitinylation). Ubiquitylation affects proteins in many ways: it can mark them for degradation via the 26S proteasome, alter their cellular location, affect their activity, and promote or prevent protein interactions. Ubiquitylation involves three main steps: activation, conjugation, and ligation, performed by ubiquitin-activating enzymes (E1s), ubiquitin-conjugating enzymes (E2s), and ubiquitin ligases (E3s), respectively. The result of this sequential cascade is to bind ubiquitin to lysine residues on the protein substrate via an isopeptide bond, cysteine residues through a thioester bond; serine, threonine, and tyrosine residues through an ester bond; or the amino group of the protein's N-terminus via a peptide bond. The protein modifications can be either a single ubiquitin protein (monoubiquitylation) or a chain of ubiquitin (polyubiquitylation). Secondary ubiquitin molecules are always linked to one of the seven lysine residues or the N-terminal methionine of the previous ubiquitin molecule.
An interesting remaining piece of Nazi architecture can be found in the former Berlin Tempelhof Airport which closed all airport operations in 2008. The main terminal was designed and built during the late 1930s and early 1940s according to a design by Ernst Sagebiel following the ideas of Speer and Hitler including that of ruin value. It was designed to be the main hub for Hitler's redesigned Berlin, to be called Germania. When completed, it was the world's largest building and today, should the building fall into disrepair, Speer and Hitler's ruin value theory may be demonstrated.
== Antibiotics == PBPs bind to β-lactam antibiotics because they are similar in chemical structure to the modular pieces that form the peptidoglycan. When they bind to penicillin, the β-lactam amide bond is ruptured to form a covalent bond with the catalytic serine residue at the PBPs' active site. This is an irreversible reaction and inactivates the enzyme. There has been a great deal of research into PBPs because of their role in antibiotics and resistance. Bacterial cell wall synthesis and the role of PBPs in its synthesis is a very good target for drugs of selective toxicity because the metabolic pathways and enzymes are unique to bacteria. Resistance to antibiotics has come about through overproduction of PBPs and formation of PBPs that have low affinity for penicillins (among other mechanisms such as lactamase production). These experiments change the structure of PBP by adding different amino acids into the protein, allowing for new discovery of how the drug interacts with the protein. Research on PBPs has led to the discovery of new semi-synthetic β-lactams, wherein altering the side-chains on the original penicillin molecule has increased the affinity of PBPs for penicillin, and, thus, increased effectiveness in bacteria with developing resistance. Presence of the protein penicillin binding protein 2A (PBP2A) is responsible for the antibiotic resistance seen in methicillin-resistant Staphylococcus aureus (MRSA). The β-lactam ring is a structure common to all β-lactam antibiotics.
Sources: en.wikipedia.org
On June 13, 2013, ESPN announced that they would end the broadcast of the ESPN 3D channel by the end of that year and would "...experiment with things like UHDTV." On June 26, 2013, Sharp announced the LC-70UD1U, which is a 70 in (180 cm) 4K Ultra HD TV. The LC-70UD1U is the world's first TV with THX 4K certification. On July 2, 2013, Jimmy Kimmel Live! recorded in 4K Ultra HD a performance by musical guest Karmin, and the video clip was used as demonstration material at Sony stores. On July 3, 2013, Sony announced the release of their 4K Ultra HD Media Player with a price of US$7.99 for rentals and US$29.99 for purchases. The 4K Ultra HD Media Player only worked with Sony's 4K Ultra HD TVs. On July 15, 2013, the CTA published CTA-861-F, a standard that applies to interfaces such as DVI, HDMI, and LVDS. The CTA-861-F standard adds support for several Ultra HD video formats and additional color spaces. On September 2, 2013 Acer announced the first smartphone, dubbed Liquid S2, capable of recording 4K video. On September 4, 2013, the HDMI Forum released the HDMI 2.0 specification, which supports 4K resolution at 60 fps. On the same day, Panasonic announced the Panasonic TC-L65WT600—the first 4K TV to support 4K resolution at 60 FPS. The Panasonic TC-L65WT600 has a 65 in (170 cm) screen, support for DisplayPort 1.2a, support for HDMI 2.0, an expected ship date of October, and a suggested retail price of US$5,999.
The predominant language today is Cantonese, a variety of Chinese originating in Guangzhou. It is spoken by 93.7% of the population, 88.2% as a first language and 5.5% as a second language. Slightly over half the population (58.7%) speaks English, the other official language; 4.6% are native speakers, and 54.1% speak English as a second language. Code-switching, mixing English and Cantonese in informal conversation, is common among the bilingual population. Post-handover governments have promoted Mandarin, which is currently about as prevalent as English; 54.2% of the population speaks Mandarin, with 2.3% native speakers and 51.9% as a second language. Traditional Chinese characters are used in writing, rather than the simplified characters used in the mainland. Before the First Opium War, Hong Kong had no significant Cantonese-speaking population. Instead, most people spoke Hakka varieties. However, large areas with speakers of other Yue Chinese varieties, namely Weitou and Tanka, can be found in the northern New Territories and southern coastal areas, respectively. Hong Kong Hakka is a variety of Neo-Hakka, and belongs to the Mei-Hui Hakka subbranch of Yuetai Hakka, making it closely related to that of Meixian. Weitou Yue is a variety that is closely related to the Yue Chinese varieties spoken in Bao'an and Dongguan, and was the primary language of the Five Great Clans of the New Territories, brought into Hong Kong during the Song dynasty from Jiangxi. Some of the native Yue Chinese varieties were noticeably Hakka-influenced.
Raicho Kimikage (君影 雷鳥, Kimikage Raichō) Agent of Summer's Guard Candidate, Ruri's fiancé. He's a confident, sometimes arrogant man. Most people consider him weird, but he's kind and devoted to those he respects. He's madly in love with Ruri. Renri Rouo (老鶯 連理, Rōō Renri) Town of Summer doctor and Ayame's fiancé. He is a doctor affiliated with the town's medical practice. Despite his playboy appearance, he is kind and gentle. He wishes to marry Ayame, but there is a big secret between them.
=== Nuclear fission === Plutonium is a radioactive actinide metal whose isotope, plutonium-239, is one of the three primary fissile isotopes (uranium-233 and uranium-235 are the other two); plutonium-241 is also highly fissile. To be considered fissile, an isotope's atomic nucleus must be able to break apart or fission when struck by a slow moving neutron and to release enough additional neutrons to sustain the nuclear chain reaction by splitting further nuclei. Pure plutonium-239 may have a multiplication factor (keff) larger than one, which means that if the metal is present in sufficient quantity and with an appropriate geometry (e.g., a sphere of sufficient size), it can form a critical mass. During fission, a fraction of the nuclear binding energy, which holds a nucleus together, is released as a large amount of electromagnetic and kinetic energy (much of the latter being quickly converted to thermal energy). Fission of a kilogram of plutonium-239 can produce an explosion equivalent to 21,000 tons of TNT (88,000 GJ). It is this energy that makes plutonium-239 useful in nuclear weapons and reactors. The presence of the isotope plutonium-240 in a sample limits its nuclear bomb potential, as 240Pu has a relatively high spontaneous fission rate (~440 fissions per second per gram; over 1,000 neutrons per second per gram), raising the background neutron levels and thus increasing the risk of predetonation. Plutonium is identified as either weapons-grade, fuel-grade, or reactor-grade based on the percentage of 240Pu that it contains.
Sources: en.wikipedia.org
Brent ( ) is a borough in west and north-west London, England; it forms part of Outer London. It is known for landmarks such as Wembley Stadium, the Swaminarayan Temple and the Kiln Theatre. It also contains the Welsh Harp reservoir and the Park Royal commercial estate. The local authority is Brent London Borough Council. Brent's population was estimated to be 353,000 as of 2024. Major districts are Kenton, Kilburn, Willesden, Wembley and Harlesden, with sub-districts Stonebridge, Kingsbury, Kensal Green, Neasden, and Queen's Park. Brent has a mixture of residential, industrial and commercial land. It includes many districts of inner-city character in the east and a more distinct suburban character in the west, part of which formed part of the early 20th century Metroland developments.
== Adverse effects == Artesunate may cause serious side effects including hemolytic anemia (a condition in which red blood cells are destroyed), and severe allergic reactions. Artesunate is generally safe and well tolerated. Artesunate-based regimens are less likely to cause vomiting and tinnitus than quinine plus anti-malarial antibiotic therapy. The best recognised adverse effect of the artemisinins is that they lower reticulocyte counts. This is not usually of clinical relevance. With increased use of I.V. artesunate, there have been reports of post-artesunate delayed haemolysis (PADH). Delayed haemolysis (occurring around two weeks after treatment) has been observed in people treated with artesunate for severe malaria.
Myxosortases, homologs of the type 2 CAAX prenyl protease Rce1, are analogous protein-sorting enzymes, but they are unlikely to function as transpeptidases. It is likely, instead, that the cysteine residue in the target sequence is modified by a separate enzyme, and that modification is followed by cleavage by the myxosortase, as happens with Rce1. The exact biochemistry of the overall modification is not yet known.
The European Union conducts cyber war game scenarios with member states and foreign partner states to improve readiness, skills and observe how strategic and tactical decisions may affect the scenario. As well as war games which serve a broader purpose to explore options and improve skills, cyber war games are targeted at preparing for specific threats. In 2018 the Sunday Times reported the UK government was conducting cyber war games which could "blackout Moscow". These types of war games move beyond defensive preparedness, as previously described above and onto preparing offensive capabilities which can be used as deterrence, or for "war".
=== Venetia Berens === Venetia Berens (Indy Lewis) is a new grad who joins Pierpoint's FX desk in the second series. She is first seen in series 1 at a Pierpoint recruiting event, pressing Robert and Yasmin on the firm's toxic culture. Ambitious and idealistic, Venetia is determined to prove herself within Pierpoint's cutthroat work environment, provoking resentment from Yasmin over not having to face the same mistreatment she suffered in her first year. In series 2, While scouting new recruits, Venetia grows closer to Robert, to whom she is attracted, but Robert humiliates her when he makes an aggressive pitch to a student while on cocaine, wherein he suggests that Venetia is merely using achievement to seek external validation. Venetia later barges into a client dinner between Robert and Nicole Craig, unaware that they are in a sexual relationship; after Robert leaves the two alone, Nicole sexually assaults Venetia. Venetia confides this to Yasmin, but she dismisses her concerns. Venetia then goes to Kenny, who attempts to report the assault up the chain of command, but to no avail. In series 3, Venetia and Robert have begun dating. Venetia, growing increasingly tired of Pierpoint's abusive work environment, eventually quits the firm. While leaving, she reveals to Rishi that she was the one who anonymously posted to a Reddit page called "Overheard At Pierpoint", which contained many of Rishi's lewd and inappropriate comments on the trading floor.
Sources: en.wikipedia.org
It is a modified version of the natural hormone, with three amino acid changes and a fatty acid side chain added. These edits extend its half-life from minutes to about one week. The core receptor activity is retained.
Both deliver the same active peptide and act on the same receptor. The tablet includes an absorption enhancer because peptides are poorly taken up intact from the gut. Bioavailability of the oral route is substantially lower, so the two are not dose-equivalent.
No, it is entirely synthetic and does not occur in nature. Native GLP-1 is produced in the gut and pancreas, but the analog is manufactured by chemical synthesis or recombinant methods. Traces of the analog are not expected in people who never received it.
It is a synthetic peptide of 31 amino acids, built to resemble the natural incretin hormone GLP-1. Because of its size and composition it is handled analytically like other therapeutic peptides, using chromatographic and mass spectrometric methods rather than the techniques typical of small organic drugs.